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Abstract A methodology using stripping voltammetry has
been elaborated to enable sensitive and reliable protein–chro-
mium complexation measurements. Disturbing effects caused
by adsorption of proteins on the mercury electrode were
addressed. At low concentrations of proteins (\60–85 nM),
chromium–protein complexation measurements were possi-
ble. Chromium(VI) complexation was quantitatively deter-
mined using differently sized, charged, and structured proteins:
serum albumin (human and bovine), lysozyme, and mucin.
Generated results showed a strong relation between com-
plexation and protein size, concentration, and the number of
amino acids per protein mass. Complexation increased non-
linearly with increasing protein concentrations. The nature of
this complexation was based on weak interactions judged from
combined results with MALDI-TOF–MS and adsorptive
cathodic stripping voltammetry.
Keywords Chromium  Complexation  Lysozyme 
Serum albumin  Mucin  Stripping voltammetry
1 Introduction
Chromium–protein complexation is an important process
in the human body where, for example, trivalent chromium
is known to maintain proper carbohydrate and lipid
metabolism at a molecular level. Cr(III) is bound to an
oligopeptide chromodulin which, when metal-saturated,
can bind to an insulin-stimulated insulin receptor and
activate the tyrosine kinase activity of the receptor [1].
Studies on chromium complexation and reported stability
constants of different organic-chromium complexes are
scarce in the literature. However, it has been shown that
Cr(III) forms complexes with different organic species,
including amino acids [2], bovine serum albumin (BSA)
[3], other proteins, and DNA [4]. It has furthermore been
shown that mainly trivalent chromium binds to proteins
and DNA [4] even if hexavalent chromium is added, with
tyrosine and cysteine, followed by histidine, methionine,
and threonine as major binding sites for chromium to
proteins [4]. Recent findings have shown that adsorption of
proteins on chromium metal and chromium-containing
alloys strongly enhances the release of metals in phosphate
buffered saline [5]. Complexing agent-induced metal
release was explained by adsorption-controlled surface
complexation and subsequent detachment of metal com-
plexes, as shown in the case of citric acid as complexing
agent compared to different non-complexing solutions of
the same pH [6]. The importance of such complexation-
induced processes, proven to enhance the extent of metal
release from chromium metal, ferrochromium alloys and
stainless steels [5–7], should be taken into consideration
when assessing potential health hazards induced by these
materials in contact with proteins, e.g., in the human body
(implants or inhaled metal particles), or in food processing.
As chromium is widely used in many industrial alloys and
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implant materials [8], there is a need for a reliable and
robust methodology to assess chromium–protein com-
plexation in different solutions.
While there is plenty of information in the literature on
the adsorption and determination of different proteins on
the mercury electrode (for reviews, see [9–12]), the infor-
mation available on chromium–protein complexation
studies using stripping voltammetry is very limited. One
exception is an early polarography study performed on the
complexation of chromium to insulin and mitochondria
[13].
Advantages and encountered difficulties of using strip-
ping voltammetry with a mercury drop electrode to assess
metal–protein complexation have been reported in the lit-
erature, e.g., [9, 14–21]. The foremost limitation of strip-
ping voltammetry for protein–metal complexation studies
is the adsorption of proteins on the charged and hydro-
phobic surface of the mercury drop, as proteins inevitable
adsorb on almost all surfaces [22]. Detailed studies on
protein adsorption on the mercury drop are hence essential
for individual proteins, concentrations, and deposition
times before evaluating the protein–metal complexation.
Most reported studies [9, 14–16, 18, 20, 23–26] have used
alternating current voltammetry or cyclic voltammetry to
explore protein adsorption on the mercury electrode [9, 10,
27]. Other studies have used scan rate-dependent mea-
surements [26–28], a procedure difficult to employ in the
differential pulse mode [28]. Scheller et al. [25] investi-
gated the limiting current of the reduction of disulfide
bridges at different concentrations of proteins in solution.
The investigation showed a linear increase with protein
concentration reaching a constant value (full coverage of
the mercury electrode). Other studies have reported [20,
24] that the extent of adsorption of proteins on the mercury
electrode depends on potential, protein charge, and ionic
strength of the solution, while the protein charge depends
on protein isoelectric point (iep, point of zero surface
charge), solution pH and solution composition. Very
promising for protein–metal binding studies are also con-
stant current chronopotentiometric stripping (CPS) analy-
sis, where the ‘‘peak H’’ is evaluated as it is sensitive to
changes in structure and binding of the protein [29–32].
The objectives of this study were to accurately assess the
extent and nature of chromium–protein complexation in
solution by using stripping voltammetry complemented
with matrix-assisted laser desorption ionization time-of-
flight mass spectrometry (MALDI-TOF–MS), and to elu-
cidate its dependence on size, charge, and structure of the
proteins [serum albumin (human and bovine), lysozyme
(LYS), and mucin]. A robust methodology had to be
elaborated for stripping voltammetry to enable these
objectives, as the adsorption of proteins on the mercury
drop interferes with the measurements.
Possibilities and limitations of using stripping voltam-
metry and MALDI-TOF–MS for chromium–protein com-
plexation measurements are discussed.
2 Materials and methods
2.1 Chemicals and cleaning
The same chemicals were used as in an adsorption and
metal release study on chromium surfaces [5]. Ultra-pure
water (18.2 MX cm) and ultra-pure chemicals (Sigma-
Aldrich) of grade puriss. p.a. including sodium acetate,
diethylenetriaminepentaacetate (DTPA), sodium nitrate,
and 30 % NaOH were used for the voltammetric studies.
Puriss. p.a. mercury (Sigma-Aldrich) was used for the
hanging mercury drop electrode (HMDE). All equipment
and plastic vessels were acid cleaned using 10 % nitric acid
(Sigma-Aldrich) to avoid any trace metal contamination.
PTFE vessels were used for the Cr(VI) standards to mini-
mize the risk of adsorption on the vessel walls. The Cr(VI)
standard of 20 lg L-1 was prepared daily from a
10 mg L-1 Cr(VI) standard, in turn prepared from a stock
solution of 1 g L-1 Cr(VI) in water (pH of*7.4), based on
K2Cr2O7 (from Sigma-Aldrich).
For the MALDI-TOF–MS measurements, 2,5-dihy-
droxybenzoic acid (DHB) and sinapinic acid (SA) and
MALDI matrices were supplied by Bruker Daltonics
(Germany). Trifluoroacetic acid (TFA), 2,6-dihydroxyace-
tophenone (DHAP), and MS calibration kit (ProteoMass
TM
)
containing cytochrome C (m/z 12,362 Da), apomyoglobin
(m/z 16,952 Da), aldolase (m/z 39211 Da), and albumin
from bovine serum (m/z 66,429 Da) were purchased from
Sigma-Aldrich (Sweden).
Acetonitrile (ACN) was obtained from VWR Interna-
tional (Sweden). The water used for the MS experiment
was purified using a Synergy 185 system from Millipore
(USA).
2.2 Investigated proteins
Proteins were purchased from Sigma-Aldrich and used as
received in all stripping voltammetry measurements. LYS
from hen egg white (L6876) is a globular ‘‘hard’’ (high
internal conformation stability) protein present in saliva
and tear fluid with the dimensions 4.5 9 3 9 3 nm and a
molecular weight of 14.1 kDa [33]. Serum albumin from
human (HSA) (A8763) and bovine (BSA) (A3912) sources
are ‘‘soft’’ globular proteins present in serum at high con-
centrations (ranging from 30 to 50 g L-1), which corre-
sponds to *60 % of the total amount of proteins present in
serum [34]. Serum albumin has an estimated triangular
structure with the dimensions 8 9 8 9 3 nm (determined
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by means of X-ray crystallography) and a molecular weight
of *66 kDa [35]. The large flexible glycoprotein bovine
submaxillary gland mucin (BSM) (M3895) with a molec-
ular weight of *7 MDa [36] has important functions in
mucous and in saliva where it binds water and thereby
lubricates the epithelial membrane. BSM exists more or
less as a random coil in solutions with a radius of gyration
of around 130 nm [37].
2.3 Solutions
Phosphate buffered saline, PBS, (8.77 g L-1 NaCl,
1.28 g L-1 Na2HPO4, and 1.36 g L
-1 KH2PO4) was
adjusted to pH 7.4 using 50 % NaOH. The proteins were
dispersed in this solution for at least 3 h before the mea-
surements to equilibrate the samples. By considering the
iep of the proteins used, LYS (iep = 11) [33] was net
positively charged at pH 6.2 (the pH of the voltammetric
measurements), BSM (iep = 3) [38] was net negatively
charged due to its high content of sialic acid, and serum
albumin, HSA and BSA (iep = 4.7) [34], also was net
negatively charged at the same experimental conditions.
Comparative chromium–protein complexation measure-
ments were done at constant protein mass concentration
(4 mg L-1) and constant molar concentration (59 nM),
respectively. They were in addition conducted for different
concentrations for BSM, i.e., 0.2, 0.3, 0.4, and 1 nM.
2.4 Metal–protein complexation studies by stripping
voltammetry
A Metrohm 797 VA Computrace instrument [hanging
mercury drop working electrode, Ag/AgCl (saturated KCl)
reference electrode, platinum auxiliary electrode] was used
for complexation measurements using differential pulse
adsorptive cathodic stripping voltammetry (DPAdCSV).
Measurements were conducted with freshly prepared pro-
tein solutions, not stored more than 2 days before use,
Milli-Q water to dilute the protein solution (total sample
volume 10 mL), and supporting electrolyte (2.5 mL) con-
taining 0.2 M sodium acetate, 0.05 M DTPA, and 2.5 M
sodium nitrate. The pH of the measured sample containing
the supporting electrolyte was adjusted to 6.2 ± 0.1 (using
30 % ultrapure NaOH).
The limit of determination for Cr(VI) was 0.02 lg L-1
and the limit of detection (detected but not determined)
was *0.01 lg L-1. Complexation measurements were
conducted by adding a known amount of standard solution
of Cr(VI) to the protein containing solution (of known
protein concentration) and measuring the free Cr(VI)
content in the solution, i.e., indirect detection of the
chromium–protein complexation.
Standard analysis (described in [39] and developed in
[40]) was performed with a pre-purging (argon) time of
300 s at the HMDE, followed by deposition (60 s, at
-1.0 V) in the differential pulse mode (pulse amplitude
50 mV), starting and ending at -1.0 and -1.45 V,
respectively, (sweep rate 33.3 mV s-1) and an equilibrium
time after each addition of Cr(VI) of 300 s. Chromium
determination using DTPA and nitrate is well established
and reviewed in [41]. The equilibrium time period after
addition of Cr(VI) to the protein solution may be important
for complexation as metal–protein complexation is time
dependent [42]. A relatively long, but still practically
feasible time (300 s), was therefore introduced between
every addition. The solutions were also stirred during this
time period and at the pre-purging time to facilitate mixing.
According to [39, 40], the chromium peak height is linearly
dependent on the free chromium concentration up to
40–90 nM Cr(VI) and reveals a relative standard deviation
of 5 % above 4 nM Cr(VI). The analyzed peak position for
the chromium signal was at a potential of -1.25 ± 0.1 V.
A typical voltammogram for chromium determination
using this methodology is shown in Fig. 1. It reflects the
reaction of the Cr3?/DTPA 1:1 complex ([Cr(H2O)HY]
-),
formed after deposition at -1 V by chromate and DTPA at
the mercury drop, to [CrH2Y]
- at -1.22 V, where ‘‘Y’’
symbolizes DTPA [43]. The presence of nitrate catalyses
the reverse reaction ([CrH2Y]
- ? [Cr(H2O)HY]
-) and
increases therefore the peak height [43].
Fig. 1 Typical voltammogram of chromium determination in a non-
complexing solution [here: 10 mL deionized water, 2.5 mL support-
ing electrolyte, and 0.1 mL 20 lg L-1 Cr(VI)], showing the sample
current–potential curves (solid lines) and measured current–potential
curves after standard addition (dashed lines). Two standard additions
and two replicate readings are shown
J Appl Electrochem (2012) 42:349–358 351
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Mercury of the grade puriss. p.a. was used throughout
the investigation. To ensure accurate measurements,
cleaning and/or an exchange of the mercury and the cap-
illary followed by an adjustment of the mercury drop size
were conducted before analysis. All measurements were
repeated at least once to prove the reproducibility.
Chromium–protein complexation studies were per-
formed by adding Cr(VI) to a protein solution of as low
protein concentration as possible. As the DPAdCSV
method for chromium determination is very sensitive to
electro-active (detectable) chromium, it was possible to use
low (nM range or lower) protein concentrations to mini-
mize the influence of protein adsorption on the mercury
drop. An alternative method for metal complexation stud-
ies, i.e., to add protein to a metal containing solution,
would enable better calculations of complexation since a
complexation model can be used [17]. However, as this
method cannot account for changing protein adsorption
conditions during the measurement, this approach was not
selected.
Cr(VI) was primarily investigated in this study due to
the high sensitivity of the DPAdCSV technique for this
species in solutions of low concentrations of proteins.
2.5 MALDI-TOF–MS measurements
As the MALDI-TOF–MS technique is regarded as a soft
ionization technique with low fragmentation, often pro-
ducing singly charged ions, it is suitable for studies of
proteins and protein complexation. A Bruker Reflex III
MALDI-TOF–MS (instrument from Bruker Daltonics with
a SCOUT 384 ion source and Flex control software) was
utilized. The methods used were optimized for 17 and
66 kDa in a linear mode.
A Bruker concentration MTP AnchorChip target plate
with 400 nm anchors was used.
Three different matrices were used: DHB, SA, and
DHAP, all at a concentration of 20 mg mL-1 dissolved in
ACN:0.1 % TFA (1:1). For all studies, the dried droplet
method was used with 0.5 lL of matrix applied to the
MALDI target followed by 0.5 lL sample solution. Mass
spectra were obtained by sweet spot searching (20 shots on
each position summed up to 200), with a laser intensity of
75 %. Peak picking was obtained with the analyzing pro-
gram XTOF using the centroid peak picking algorithm
(Bruker Daltonics).
Cytochrome C, apomyoglobin, aldolase, and albumin
from bovine serum at a concentration of 1 lM each were
used for calibration.
Investigated samples included BSA and LYS (at con-
centrations of 1 lM without any chromium added) and
each protein mixed with Cr(VI) to predetermined molar
ratios (chromium to protein). The protein concentrations
were adjusted to a molar ratio of 1:1 [19.2 lM
Cr(VI):19.2 lM BSA] and 27:1 [173 lM Cr(VI):6.4 lM
BSA], and of 1:3 [19.2 lM Cr(VI):57.6 lM LYS] and 9:1
[173 lM Cr(VI):19.2 lM LYS)].
3 Results and discussion
To enable studies of chromium–protein complexation
using differently sized and charged proteins by means of
stripping voltammetry, the known interference of protein
adsorption on the HMDE had to be investigated for the
specific proteins investigated. In the following, the extent
of protein adsorption of the HMDE was explored for BSM,
HSA/BSA and LYS, and the extent of protein–chromium
complexation determined at low protein concentrations by
means of stripping voltammetry and MALDI-TOF–MS.
3.1 Protein adsorption on mercury
The extent of protein adsorption onto the HMDE during the
chromium–protein complexation measurement depends not
only on protein concentration but may also depend on the
chromium concentration in solution, as for instance Cr–
DTPA complexes (via the supporting electrolyte) may
competitively adsorb on the HMDE surface. This possi-
bility was not taken into account during the adsorption
studies. However, due to the larger size of the proteins, we
expect the proteins to have a higher affinity for the HMDE
surface compared to the small Cr–DTPA complexes as a
consequence of gained entropy due to an exchange from
counter-ions of the electrolyte to adsorbed proteins. The
extent and influence of protein adsorption were evaluated
by analyzing a reduction peak induced by the proteins at
approximately -1.1 V (vs. Ag/AgCl), c.f. Fig. 2a, b. In
Fig. 2a, b, the current–potential curve corresponding to the
maximum peak of the concentration range (c.f. Figs. 3, 4)
is shown, i.e., 0.016 and 0.018 g-L-1 for LYS,
0.014 g L-1 for HSA, and 0.6 g L-1 for BSM. The
reduction process used to assess the amount of protein
adsorption is unclear, however, similar data has been
reported elsewhere [6, 9, 10, 44]. Several polarographic
studies have observed a similar peak at -0.9 to -1.2 V (vs.
SCE) at high (lM) protein concentrations [10] attributed to
irreversibly [44] accepted electrons at the –S–S– bonds [9].
The reduction peak of this study was observed at signifi-
cantly lower (nM) protein concentrations but of lower
height at high (lM) concentrations compared to the liter-
ature findings. A similar peak has previously been observed
for a sodium pyruvate solution in which –S–S– bonds were
not present (but a C=O group) [6], c.f. Fig. 2c. These
observations imply another possible reason for the reduc-
tion peak, namely the reduction of any accessible C=O
352 J Appl Electrochem (2012) 42:349–358
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group. Similar interpretations have been reported in Cosma
et al. [45] reporting a weak peak at -1.0 to -1.1 V versus
SCE in addition to a strong peak at -0.66 V versus SCE
attributed to chlorophyll A. The presence of the reduction
peak in this study originating from the protein solution (c.f.
Fig. 2a, b) was not as pronounced as in the case of the
sodium pyruvate solution (Fig. 2c). At present, this is not
fully understood. The peak height was for all proteins
concentration-dependent. As LYS was the only net posi-
tively charged protein at pH 6.2, it is furthermore expected
to be adsorbed to a larger extent, and possibly to form
stronger bonds at the negatively charged mercury electrode
compared with the other proteins.
The adsorption of proteins on the HMDE was studied by
continuously adding proteins to an initially protein-free
electrolyte solution and analyzing changes in the protein
peak height (proportional to changes in peak area, as the
peak width is constant). Changes in peak height versus the
total protein concentration are illustrated for LYS in Fig. 3.
An increased concentration initially resulted in an
increased peak height that reached a maximum before it
decreased and finally approached an almost constant value.
This initial increase reaching a maximum is in concordance
with previous studies on protein adsorption on mercury
[25]. However, to the best of the knowledge of the authors,
no other studies have reported decreasing peak heights and
finally almost constant values at higher protein concentra-
tions. A hypothesis is proposed to explain this observation.
At low adsorption of proteins at the mercury drop (no
peaks or linear increase of peak height), both adsorbed
proteins and proteins in solution contribute to the peak
height. The contribution from proteins in solution is
reduced as the protein adsorption on the mercury drop
increases (as visible as a slower increase of peak height,
followed by decreasing peak height). Finally, at constant
peak heights, only proteins adsorbed at the mercury drop
surface are proposed to contribute to the observed peak as
proteins in solution are shielded from the mercury surface.
According to measurements of Stankovich and Bard [46]
investigating the effect of scan rate and concentration of
insulin solutions, the reduction wave at -1.2 V versus SCE
was shown to be mostly diffusion-controlled (solution
species) rather than adsorption-controlled. Findings of this
study suggest that both diffusion and adsorption control are
possible but largely related to the protein concentration.
Adsorption control was evident in the case of high LYS
concentrations ([1,000 nM, Fig. 3), an effect clearly
illustrated by two independent measurements, Fig. 3. As
the mercury drop size was slightly different between the
measurements, the absolute values are different but the
trends are similar. The first set of data was compiled over a
more narrow concentration range (1,100–13,000 nM)
compared to the second set, covering a much wider range
(4–26,000 nM). Generated results show a minor influence
of protein adsorption on the mercury drop at LYS con-
centrations \265 nM (no peak height or linear increase),
however, as it was difficult to see any linearity between 60
and 265 nM, it is more safe to take a threshold value of
60 nM (0.0008 g L-1), below which no peak was
observed.
Analogous investigations conducted for HSA and BSM
(net negatively charged at pH 6.2, same as the mercury
drop) are illustrated in Fig. 4. Non-reproducible threshold
values were obtained for both proteins. No significant
effect of protein adsorption on the mercury drop was
observed for concentrations up to 85 nM for BSM, and up
to 211 nM for HSA, in a first measurement. For these
proteins (net negatively charged at pH 6.2, same as the
mercury drop), the peak corresponding to the protein (at -
1.1 V) increased linearly with added concentration. How-
ever, in a second measurement using the same batch and
preparation, but slightly different mercury drop size, a
Fig. 2 Current–potential curves of solutions (the same conditions as
for chromium determination, see ‘‘Materials and methods’’) contain-
ing a two independent replicate measurements of LYS, b HSA and
BSM, and c 0.7 g L-1 sodium pyruvate (C3H3O3Na). Inset graph The
same current scale as for sodium pyruvate (c). The protein concen-
trations that resulted in the maximum peaks which are shown here
were 0.016 and 0.018 g L-1 for LYS, 0.014 g L-1 for HSA, and
0.6 g L-1 for BSM
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poorly resolved peak (at -1.1 V) was observed due to
protein reduction. This peak could not be quantified in the
case of BSM and was difficult to quantify for HSA. For
BSM, the signal was \0.1 nA, and for HSA, adsorption
was non-significant up to 85 nM (linear increase of peak
height), Fig. 4, which is in contrast to the first measurement
([211 nM).
The poor reproducibility between the different mea-
surements for HSA, Fig. 4, and BSM could be attributed to
small differences of the mercury drop size that may result
in slight differences in surface charge (still net negatively
charged), effects not crucial for the adsorption of LYS
being net positively charged, but notable for BSM and
HSA being net negatively charged. From these adsorption
studies, it was assumed that a protein concentration
exceeding 60 nM of LYS, 85 nM of BSM, and 85 nM of
HSA/BSA resulted in an adsorption of proteins on the
mercury drop that hindered accurate studies of proteins in
solutions and hence protein-complexation studies. In
addition, the protein peak potential shifted to more
negative potentials for all proteins investigated (LYS,
HSA, and BSM) with increasing protein concentrations,
i.e., up to 40 mV for LYS, 50 mV for BSM, and 55 mV for
HSA. This shift was not pronounced at the low concen-
trations proposed for complexation studies. Similar shifts
to more negative potentials due to adsorption processes
have been previously reported for peptides and fulvic
substances [23, 26].
3.2 Chromium–protein complexation—influence
of protein type and protein concentration
To form a stable chromium complex, the protein must first
reduce Cr(VI) (as negatively charged chromate) to Cr(III)
(positively charged) [47]. As Cr(III) results in significantly
lower signals using DPAdCSV, an electrochemical reduc-
tion of Cr(VI) to Cr(III) taking place that is not induced by
the formation of protein–chromium complexes may erro-
neously be assigned as protein complexation. Investiga-
tions were therefore conducted with BSM (negatively
Fig. 3 Peak height
corresponding to LYS over the
accumulated LYS molar
concentration obtained at a
potential of -1.10 V versus the
Ag/AgCl/KCl sat. reference
electrode. The first (LYS_1) and
second (LYS_2) sets of data
were generated using different
LYS solutions of the same batch
Fig. 4 Peak height (-1.05 to
-1.10 V) corresponding to
mucin (BSM) and human serum
albumin (HSA) proteins over
the accumulated protein
concentrations. The same
protein solutions as used in the
comparative chromium
complexation capacity studies
are used for the first
measurement of BSM (BSM_1)
and HSA (HSA_1)
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charged) to assess if a Cr(III) addition, instead of a Cr(VI)
addition, would result in different chromium–protein
complexation. Differences in complexation between dif-
ferently charged chromium species and charged proteins
could be a consequence of electrostatic repulsion between
similar charged species. No significant complexation was
observed either with Cr(VI) or with Cr(III) [linearly
increasing signal with addition of Cr(III) (R2 = 0.993) and
for Cr(VI) (R2 = 0.995)] at a protein concentration of
0.6 nM (0.004 g L-1) (data not shown). The measurements
were performed with a significantly shorter equilibrium
time after the addition of Cr(III), only 5 s compared with
300 s [for Cr(VI)], due to a decreasing signal of Cr(III)
with time [41]. Even though these findings imply similar
results independent of chromium speciation in the case of
BSM, the situation may be different for LYS, HSA, and/or
BSA (not investigated in this study) as suggested by
Tkaczyk et al. for BSA [3]. The approach of this study
should at this stage hence be only applied for the meth-
odology adding Cr(VI).
Chromium–protein complexation investigations by
means of stripping voltammetry were conducted for pro-
teins of varying size, charge, and structure (LYS, BSA,
HSA, and BSM) in concentrations lower than the proposed
threshold values to minimize the effect of adsorbed pro-
teins on the HMDE surface, with the exception of LYS at
280 nM, Fig. 5. The results are presented both as a func-
tion of given mass concentration (4 mg L-1), Fig. 5, and
given molar concentration (59 nM), Fig. 6.
Generated results for the same solution without any
proteins are included for comparison and show a relatively
linear increase of the chromium peak height with added
Cr(VI) (Figs. 5, 6). At 40 nM Cr(VI), the peak height was
*175 nA for the solution without proteins. At low mass
concentrations of BSM (0.6 nM, Fig. 5) and at low molar
concentration of LYS (59 nM, Fig. 6), the chromium sig-
nal was enhanced compared to the non-protein containing
solution. This has also been previously observed for gly-
cine [6]. This catalytic effect is known for nitrate which
therefore is a component of the supporting electrolyte with
the function to enhance the signal by oxidizing Cr(II)–
DTPA back to Cr(III)–DTPA [41].
Observed differences in complexation capacity with
chromium correlated with corresponding protein size
(BSM [ HSA/BSA [ LYS). At constant mass concentra-
tion, Fig. 5, the molar concentration of BSM was the
lowest (0.6 nM), followed by BSA/HSA (59 nM) and LYS
of 281 nM. LYS, with the highest molar concentration,
resulted in the strongest complexation to added chromium,
which partially also could be an effect of protein adsorption
on the HMDE, while BSM of very low molar concentration
(0.6 nM) did not result in any complexation [an initially
relatively linear increase in peak height with added
Cr(VI)].
According to the findings of this study, the number of
amino acid groups available for complexation plays a lar-
ger role in the metal complexation process compared with
the structure of the protein or protein charge. For example,
even though BSM has a large carbohydrate content that
constitutes *80 % of the total protein by mass [48], it has
a larger number of amino acid groups compared with LYS
and BSA due to its large molecular size (7,000 kDA) in
Fig. 5 Stripping voltammetry measurements of free non-complexed
Cr(VI) (peak height) as a function of known concentration of Cr(VI)
(by addition) in protein solutions (BSM—0.6 nM, BSA—59 nM,
HSA—59 nM, LYS—281 nM) of constant mass concentration
(3.97 mg L-1). A reference electrolyte containing no protein (single
measurement) is included for comparison. Data is based on one
measurement with two replicate readings (error bars) for BSM and
LYS, and on two separate measurements, each with two replicate
readings for BSA and HSA. The dotted lines are only added as visual
guides
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comparison to LYS (14.1 kDa, 129 amino acids per protein
[33]) and BSA (66 kDA, 582 amino acids per protein [49])
at the same molar concentration. As a consequence, BSM
also has the highest degree of chromium complexation,
Fig. 6. In comparison, LYS has the largest number of
amino acids at constant mass concentration compared to
BSM and BSA, Fig. 5, and therefore the highest chromium
complexation.
The results clearly show that LYS, the smallest protein
investigated, formed the significantly largest number of
chromium complexes per mass unit of protein, Fig. 5,
followed by a significantly lower complexation to chro-
mium for HSA and BSA, and BSM. In contrast, at constant
molar concentration, Fig. 6, the largest protein, BSM,
formed the largest number of chromium complexes, fol-
lowed by HSA/BSA [approximately one chromium every
20th protein, based on the amount of added Cr(VI) without
giving any signal (3 nM) in a 59 nM protein solution], and
LYS, which showed no measurable complexation at this
concentration.
Detailed studies on the effect of protein concentration on
chromium complexation were conducted with BSM. To
avoid any significant adsorption of BSM on the mercury
drop, low protein concentrations, 1 nM and less, were
investigated, Fig. 7. From the results, it was evident that
complexation [corresponding to the reduction signal of free
non-complexed Cr(VI)] increased nonlinearly with
increasing concentration. At the highest molar concentra-
tion investigated (1 nM BSM), *18 chromium ions were
complexed to one protein. At lower BSM concentrations,
complexation could not be quantified but was significantly
lower. The observed nonlinearity of BSM to chromium
complexation in this concentration interval could be an
effect of the sum of two processes, (i) enhancement of the
chromium signal, similar to the effect of nitrate [41], as
previously discussed and (ii) lowering of the signal by
protein complexation to chromium.
MALDI-TOF–MS measurements were conducted for
comparison and to possibly support the findings by means
of stripping voltammetry measurements, Fig. 8. The best
mass spectra to investigate complexation were obtained
with DHAP, in comparison to DHB and SA, although all
matrices showed the same results regarding complexation.
The DHAP matrix is considered as a soft matrix, suitable
for studies of protein quaternary structures and non-cova-
lent protein complexes [50]. Any bonding of chromium to
the protein investigated would result in a positive mass
shift of 52 Da for each chromium entity when compared to
the native mass of the protein. No strong bonds were evi-
dent between chromium and any of the proteins investi-
gated (LYS and BSA), Fig. 8, as no significant mass shifts
or additional peaks evident for chromium complexation
were observed. A degraded MS-signal was observed for
the highest chromium concentrations [27:1 and 9:1
Cr(VI):protein, for BSA and LYS, respectively], Fig. 8a
(top), an effect possibly induced by the increased ion
concentration, even though MALDI is generally regarded
as a relatively high ionic strength tolerant MS-method. The
correct mass of the peak was difficult to be determined
from the broad peak, and no clear indication of a mass shift
was observed despite the high chromium to BSA ratio
(27:1) investigated. The results clearly show that there
Fig. 6 Stripping voltammetry measurements of free non-complexed
Cr(VI) (peak height) as a function of known concentration of Cr(VI)
(by addition) in protein solutions (BSM—0.4 g L-1, BSA—
0.004 g L-1, HSA—0.004 g L-1, LYS—0.0008 g L-1) of constant
molar concentration (59 nM). A reference electrolyte containing no
protein (single measurement) is included for comparison. Data based
on one measurement with two replicate readings (error bars) for BSM
and LYS, and on two separate measurements, each with two replicate
readings for BSA and HSA. The dotted lines are only added as visual
guides
356 J Appl Electrochem (2012) 42:349–358
123
were no strong interactions such as covalent bonds between
the proteins and chromium. Similar conclusions were
drawn from stripping voltammetry measurements as no
visible peak shifts [13] of either the chromium peak at
-1.22 V or the protein peak (both at different protein
concentrations) were observed (data not shown).
However, weaker associations such as electrostatic
interactions and interactions of less than one chromium per
protein may still take place, but it is possible that these will
not be detected with MALDI-TOF–MS.
Both methods used, stripping voltammetry and
MALDI-TOF–MS, imply weak chromium complexation
with BSA and LYS, at those conditions studied. Further
studies should include evaluation of the ‘‘peak H’’,
shown to be sensitive to protein changes [11, 29–32] as
well as electrochemical investigations to possibly assess
different binding of trivalent and hexavalent chromium
to proteins, as this study only investigates hexavalent
chromium.
4 Conclusions
Stripping voltammetry and MALDI-TOF–MS measure-
ments were conducted aiming for an in-depth understand-
ing of chromium complexation with proteins of different
concentration, structure and charge. The following main
conclusions are drawn:
• The effect of protein adsorption at the hanging mercury
drop needs to be taken into account when using
stripping voltammetry for studies of metal–protein
complexation in solution. As the extent of adsorption
is strongly related to protein concentration, reproduc-
ible complexation studies can only be conducted in
solutions of low protein concentration [\60 nM (LYS)
and \85 nM (HSA/BSA/BSM)].
• Chromium complexation was favored by an increased
protein size and by an increased molar concentration of
proteins in solution. The highest complexation per mass
Fig. 7 Stripping voltammetry
measurements of free non-
complexed Cr(VI) (peak height)
as a function of known
concentration of Cr(VI) (by
addition) in BSM solutions of
different molar concentrations
(0.2, 0.3, 0.4, and 1.0 nM). A
reference electrolyte containing
no protein (single measurement,
0 nM BSM) is included for
comparison
Fig. 8 Mass spectra of a BSA [M?H]? and b LYS [M?H]?
generated by means of MALDI-TOF–MS. Lower spectra Pure protein
(1 lM), middle spectra Cr(VI) to protein ratio of 1:1 (BSA) and 3:1
(LYS), and upper spectra Cr(VI) to protein ratio of 27:1 (BSA) and
9:1 (LYS). The spectra are offset for clarity
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was evident for LYS, the protein with the largest
number of amino acid groups per mass (and net
positively charged), compared with BSA/HSA and
BSM. BSM showed in contrast the highest complex-
ation to chromium at identical molar concentration
compared with LYS and BSA/HSA due to its larger
number of amino acid groups per mole protein.
• Generated results by means of both stripping voltam-
metry and MALDI-TOF–MS measurements suggest
weaker interactions such as electrostatic interactions
between chromium and protein in solution rather than
stronger interactions such as covalent bonding. This
interpretation is justified from the absence of any peak
shift of either the protein or the chromium peak in the
stripping voltammogram and by the absence of peak
shifts in the mass spectra of MALDI-TOF–MS.
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